Topics

R&D Focus: New report shows nearly 600 medicines in development for pediatric patients

08:00 EST 13 Feb 2020 | PhRMA

America’s biopharmaceutical researchers are committed to studying, developing and testing medicines to meet the unique needs of pediatric patients. New treatment options for infants, children and adolescents can be complex and often require different clinical approaches than adult treatment pathways. According to a new report released today, there are nearly 600 pediatric medicines currently in development.

Original Article: R&D Focus: New report shows nearly 600 medicines in development for pediatric patients

NEXT ARTICLE

More From BioPortfolio on "R&D Focus: New report shows nearly 600 medicines in development for pediatric patients"

Quick Search

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...